Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orly Vardeny

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Pharmacotherapy|December 25, 2009
Key articles related to complementary and alternative medicine in cardiovascular disease: part 1Sheryl L Chow, Michael P Dorsch, Steven P Dunn, et al.
Journal of the American Heart Association|March 26, 2017
An <i>NPPB</i> Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and MortalitySara B Seidelmann, Orly Vardeny, Brian Claggett, et al.
Circulation. Heart Failure|March 12, 2015
Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community studyHicham Skali, Amil Shah, Deepak K Gupta, et al.
Pharmacotherapy|February 13, 2013
Key articles and guidelines in the acute management and secondary prevention of ischemic strokeWilliam L Baker, Joel C Marrs, Lindsay E Davis, et al.
Pharmacotherapy|February 13, 2013
Key articles and guidelines in the primary prevention of ischemic strokeWilliam L Baker, Joel C Marrs, Lindsay E Davis, et al.
JACC. Heart Failure|January 1, 2021
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19Ankeet S Bhatt, Karola S Jering, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|October 1, 2022
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Brian L Claggett, Orly Vardeny, et al.
JACC. Heart Failure|June 24, 2023
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HFBiykem Bozkurt, Gianluigi Savarese, Samuel Adamsson Eryd, et al.
JACC. Heart Failure|January 24, 2014
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities)Orly Vardeny, Deepak K Gupta, Brian Claggett, et al.
Heart Failure Reviews|May 21, 2025
Heart failure with preserved ejection fraction therapeutics: in search of the pillarsAbdelghani El Rafei, Josephine A Harrington, Caio A M Tavares, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Pharmacotherapy|December 25, 2009
Key articles related to complementary and alternative medicine in cardiovascular disease: part 1Sheryl L Chow, Michael P Dorsch, Steven P Dunn, et al.
Journal of the American Heart Association|March 26, 2017
An <i>NPPB</i> Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and MortalitySara B Seidelmann, Orly Vardeny, Brian Claggett, et al.
Circulation. Heart Failure|March 12, 2015
Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community studyHicham Skali, Amil Shah, Deepak K Gupta, et al.
Pharmacotherapy|February 13, 2013
Key articles and guidelines in the acute management and secondary prevention of ischemic strokeWilliam L Baker, Joel C Marrs, Lindsay E Davis, et al.
Pharmacotherapy|February 13, 2013
Key articles and guidelines in the primary prevention of ischemic strokeWilliam L Baker, Joel C Marrs, Lindsay E Davis, et al.
JACC. Heart Failure|January 1, 2021
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19Ankeet S Bhatt, Karola S Jering, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|October 1, 2022
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Brian L Claggett, Orly Vardeny, et al.
JACC. Heart Failure|June 24, 2023
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HFBiykem Bozkurt, Gianluigi Savarese, Samuel Adamsson Eryd, et al.
JACC. Heart Failure|January 24, 2014
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities)Orly Vardeny, Deepak K Gupta, Brian Claggett, et al.
Heart Failure Reviews|May 21, 2025
Heart failure with preserved ejection fraction therapeutics: in search of the pillarsAbdelghani El Rafei, Josephine A Harrington, Caio A M Tavares, et al.
Pageof 17